
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
6.18BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US69366J2006
CUSIP
69366J200
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.81
Book Value
-2.18
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.54
Wall Street Target Price
96.07
EPS Estimate Current Year
1.32
EPS Estimate Next Year
2.74
EPS Estimate Current Quarter
-0.44
EPS Estimate Next Quarter
-0.46
Most Recent Quarter
-
Revenue TTM
827,110,016
Gross Profit TTM
316,982,016
EBITDA
-20,901,000
Profit Margin
-22.58%
Return On Assets TTM
-1.54%
Return On Equity TTM
-7740.12%
Revenue Per Share TTM
10.257
Qtly Revenue Growth YOY
-76.80%
Diluted Eps TTM
-2.54
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
38
Price Sales TTM
7.5738
Price Book MRQ
1743.2734
Enterprise Value Revenue
5
Enterprise Value EBITDA
6
760.00
3.03%22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%476.99
-0.98%204.11
-0.83%